OLD API WIND-DOWN LTD.

Insiders Old API Wind-down Ltd.

Equities

ARLZQ

CA03852X1006

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2019	Old API Wind-Down Ltd. Announces Management Changes	CI
2019	Aralez Pharmaceuticals Inc. has Changed its Name to Old API Wind-down Ltd	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aralez Pharmaceuticals Inc. has Changed its Name to Old API Wind-down Ltd	06/02/19	CI
Aralez Pharmaceuticals Inc. Announces Management Changes	18/01/19	CI
Aralez Pharmaceuticals Inc. Announces the Resignation of Seth A. Rudnick, Neal F. Fowler and Rob Harris as Directors	14/08/18	CI
Aralez Pharmaceuticals Inc. Announces Resignation of James Tursi as Chief Medical Officer, Effective from August 2, 2018	26/07/18	CI
Aralez Pharmaceuticals Inc. Announces Resignation of Mark Glickman as Chief Commercial Officer, Effective on March 30, 2018	21/03/18	CI
Aralez Pharmaceuticals Inc. Appoints Michael Kaseta as Chief Financial Officer	14/03/18	CI
Aralez Pharmaceuticals Inc. Announces Resignation of Jason M. Aryeh as Board Member	07/06/17	CI
Aralez Pharmaceuticals Inc. Appoints James L. Hall as General Manager of Tribute, Effective May 16, 2016	10/05/16	CI
Aralez Pharmaceuticals Inc. Announces Board Changes	05/02/16	CI
POZEN Inc. Announces Management Changes	28/12/15	CI
POZEN Inc. Announces Executive Changes	14/09/15	CI
POZEN Inc. Appoints Scott Charles Senior Vice President of Finance	27/07/15	CI
POZEN Inc. Announces Executive Appointments	22/06/15	CI
POZEN Inc. Announces Management Changes	01/06/15	CI
POZEN Inc. Promotes Dennis McNamara to Senior Vice President and Chief Business Officer	02/01/14	CI
POZEN Announces Retirement of Elizabeth Cermak as Executive Vice President and Chief Commercial Officer, Effective January 1, 2014	06/11/13	CI
Jacques Rejeange to Resign as Board of Director of POZEN Inc	27/02/13	CI
POZEN Inc. Announces Retirement of Tom S Bocanegra as Executive Vice President, Development of the Company, Effective October 31, 2012	22/10/12	CI
POZEN Inc. Announces Intension of James J. Mauzey and Angela M. Larson Not to Stand for Reelection as Class III Director	22/03/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer